New drugs and new uses for existing drugs which act on the uterus: Gynaecology

New drugs and new evidence which might a

New drugs and new evidence which might affect the usage of existing drugs which act on the pregnant uterus

✍ Morgan, D.J.; Lamont, R.F. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 743 KB

Drug repositioning: identifying and deve

Drug repositioning: identifying and developing new uses for existing drugs

✍ Ashburn, Ted T.; Thor, Karl B. 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 190 KB

Drug repositioning: identifying and deve

Drug repositioning: identifying and developing new uses for existing drugs

✍ Ashburn, Ted T.; Thor, Karl B. 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 190 KB

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Mining Scientific and Clinical Databases to Identify Novel Uses for Existing Drugs

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 196 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.

New Uses for Older Drugs: The Tales of A

New Uses for Older Drugs: The Tales of Aspirin, Thalidomide, and Gabapentin

✍ Sirven, Joseph I. 📂 Article 📅 2010 🏛 Mayo Clinic 🌐 English ⚖ 121 KB

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Predicting the Polypharmacology of Drugs: Identifying New Uses through Chemoinformatics, Structural Informatics, and Molecular Modeling-Based Approaches

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 282 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.